NanoMed Targeting Systems (NTS) is to developing magnetically targeted drug delivery systems. This platform system is based on proprietary superparamagnetic nanoparticles attached to the drug, and its non-invasive proprietary magnetic guiding system. NTS currently working on system to treat Atrial Fibrillation, and Post Operative AF. The company has done successful pre-clinical trials, and it is getting ready for clinical trials.